Kimberly-Clark (KMB) Q2 2026 Prepared Remarks earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 Prepared Remarks earnings summary
1 Sep, 2026Executive summary
Achieved net sales of $4.2 billion in Q2 2026, up 0.6% year-over-year, with organic sales flat due to China social media disruption impacting diaper sales.
Adjusted operating profit rose 6.2% to $757 million, driven by productivity savings and one-time tariff refunds, despite headwinds from business exits and China disruption.
Adjusted EPS from continuing operations increased 10.4% to $1.80, supported by operating profit growth, lower net interest expense, and higher equity income.
Transformation initiatives advanced, including the Arbex joint venture with Suzano, Kenvue acquisition progress, and launch of a proprietary alternative natural fiber innovation program.
Innovation and marketing momentum continued in North America and international focus markets, with share gains in Vietnam, India, Indonesia, and Australia.
Financial highlights
Q2 2026 net sales were $4.2 billion (+0.6%); H1 net sales were $8.4 billion (+1.6%).
Q2 adjusted operating profit was $757 million (+6.2%); H1 adjusted operating profit was $1.5 billion (+4.9%).
Q2 adjusted EPS from continuing operations was $1.80 (+10.4%); H1 was $3.40 (+4.6%).
Adjusted free cash flow for H1 reached $1.1 billion, on pace for $2 billion for the full year.
Cash provided by operations in H1 was $1.7 billion; capital spending was $776 million; $843 million returned to shareholders via dividends.
Outlook and guidance
2026 organic sales growth expected to be ~100 basis points below category average due to China disruption.
Adjusted operating profit projected to grow mid-single digits (constant currency); adjusted EPS from continuing operations to grow high single digits.
Adjusted EPS attributable expected to see a low single-digit decline (constant currency).
Full-year capital spending is expected to be ~$1.3 billion, including transformation-related investments.
Free cash flow guidance maintained at ~$2 billion.
Latest events from Kimberly-Clark
- Adjusted EPS rose 10.4% in Q2 2026, but China disruption led to a cautious outlook.KMB
Q2 2026 (Q&A) - Kenvue integration and innovation drive growth, productivity, and strong shareholder returns.KMB
23rd annual dbAccess Global Consumer Conference - Strong growth, strategic acquisitions, and board elections defined the meeting's outcomes.KMB
AGM 2026 - Transforming through innovation and acquisitions to build a global health and wellness leader.KMB
Barclays 18th Annual Americas Select Conference - Acquisition targets $1.9B in synergies, leveraging complementary strengths for growth.KMB
Morgan Stanley Global Consumer & Retail Conference 2025 - A $48.7B merger forms a global health leader, targeting $2.1B in synergies by 2029.KMB
M&A Announcement - Q3 2024 delivered higher adjusted EPS and profit, reaffirming a strong 2024 outlook.KMB
Q3 2024 - Premiumization, innovation, and efficiency drive double-digit shareholder returns and growth.KMB
Deutsche Bank dbAccess 2024 Global Consumer Conference - 2025 targets volume-led growth, margin gains, and SG&A savings amid FX and divestiture headwinds.KMB
Q4 2024